A fifty-seven-year-old man who owns a commercial haulage company in Karu is admitted through the emergency entrance of a busy private hospital on a Saturday night with a blood pressure the triage nurse reads twice before she believes it, a headache that has been building since Thursday, and the beginnings of a stroke that will take the strength from the right side of his body over the next thirty-six hours. He runs a fleet of trucks moving goods along the roads out of Abuja. He has not, by his own account, been unwell — he has been busy, which in his vocabulary and in the vocabulary of most of his generation is a different and more respectable thing. His blood pressure, it will emerge over the following days as the family assembles the fragments of his medical history, has been readable at crisis levels for at least four years. He has bought the tablets twice, from two different pharmacies, on two occasions separated by many months, each time after a wedding or a funeral at which someone his age had collapsed. He took the first pack until it ran out. He did not refill it. Nobody called to ask whether he had. The hospital that receives him on Saturday night is genuinely excellent at receiving him — the CT scanner is working, the physician on call is competent, the stroke is managed to a standard that would not embarrass a hospital anywhere. What that hospital was never structured to do, in the four years during which this was preventable, was to reach out into the man's ordinary week and stop him from arriving at all.
This is the paradox the country has not looked at squarely. The hospitals are busier than they have ever been. The waiting rooms are full, the wards are full, the emergency entrances receive a heavier throughput each year — and the burden of chronic disease that fills those wards is not falling. It is climbing. The two observations are usually held apart, as if the busyness were the cure and the disease were the problem the busyness is slowly defeating. They are not held apart correctly. The busyness and the worsening are the same phenomenon seen from two angles, and the reason they coexist is structural, not accidental.
The system waits for the crisis
The defining characteristic of Nigerian healthcare, private and public alike, is that it is reactive medicine — a system organised almost entirely around the moment of crisis and almost not at all around the long approach to it. The architecture assumes a well person who becomes, at some identifiable point, a sick person, and it switches on at that point. The emergency entrance, the admission, the investigation, the procedure, the discharge — the whole apparatus is built to be excellent at the acute event. It is genuinely good at the acute event. A Nigerian private hospital in 2026 will manage a myocardial infarction, a diabetic emergency, an obstructed labour, or an acute abdomen with a competence that would have been unimaginable two decades ago.
The trouble is that the diseases now doing the most damage to Nigerian adults do not announce themselves as acute events until very late. Hypertension is silent for years. Type 2 diabetes is silent for years. Chronic kidney disease is silent until the kidneys are most of the way gone. The cancers that kill the most Nigerians are the ones that are found late because nobody was looking early. These are not conditions that arrive at the emergency entrance in their treatable phase. They arrive at the emergency entrance in their expensive, disabling, sometimes terminal phase — and by then the reactive system, however excellent, is doing damage control on a problem that had a decade-long open window during which almost nobody was watching.
The haulier in Karu did not have a sudden disease. He had a slow one that the system only became interested in on the night it became a fast one. The busyness of the hospital that received him is real. It is also, in the deepest sense, a measure of how many slow diseases the country is allowing to run to completion before anyone intervenes.
Nobody is paid to stop the admission
The reason prevention keeps losing to reaction is not that Nigerian clinicians do not understand prevention. They understand it perfectly well; it is in every textbook they trained on. The reason is that prevention failure is built into the structure of who does what and who gets paid for it. There is no person, in the ordinary Nigerian care pathway, whose defined job is to keep a given patient out of the hospital. The physician sees the patient who has come to be seen. The hospital admits the patient who has come to be admitted. The pharmacy sells the tablets to the patient who has come to buy them. Every actor in the chain responds to a patient who has already presented. None of them owns the interval between presentations, which is precisely the interval in which chronic disease is either controlled or allowed to progress.
Consider what would have had to happen for the haulier's stroke to be prevented. Someone would have needed to measure his blood pressure at a point when he felt entirely well and had no reason to attend a hospital. Someone would have needed to start him on treatment and — this is the part that never happens — to keep him on it, to notice when the first pack ran out and was not refilled, to phone him, to bring him back, to check that the pressure had actually come down and to adjust the regimen when it had not. That is not a single clinical act. It is a sustained relationship conducted mostly in the absence of any acute complaint, and there is no line in the Nigerian health economy that funds it. The consultation is funded when the patient is sick. The admission is funded when the patient is very sick. The long, quiet, unglamorous work of keeping a well person well is funded by nobody, structured by nobody, and owned by nobody. It therefore does not happen, and the ward fills.
The public conversation tends to frame this as a failure of patient discipline — the man who did not refill his tablets, the woman who did not attend her follow-up, the executive who did not do his annual physical. That framing is comfortable because it locates the fault in the patient. It is also mostly wrong. Patients behave, in the aggregate, exactly as the system is built to make them behave. A system that only ever contacts you when you present, and never reaches out into the interval, trains you to think of medicine as a thing you do when something is wrong. The haulier did not fail to understand that his blood pressure mattered. He understood it well enough to buy the tablets twice. What he never had was anyone whose job it was to close the loop.
The hospital grows with every bed it fills
Here is the part of the argument that is uncomfortable to state plainly, and worth stating plainly for exactly that reason. The economics of a hospital reward the filled bed, not the empty one. A hospital is a substantial fixed-cost enterprise — the building, the scanners, the theatres, the salaried staff — and it recovers those costs, and grows, by putting patients through the beds and the theatres and the scanners. Every admission is revenue. Every procedure is revenue. Every additional patient who arrives at the emergency entrance is, in the language of the enterprise, throughput. The institution's growth is coupled, directly and almost inescapably, to the volume of sickness passing through it.
This is not a claim that Nigerian hospitals are staffed by cynics who wish their patients ill. They are not. The individual doctor at the bedside wants the individual patient to recover and go home, and works hard to bring that about. The incentive misalignment operates a level above the individual doctor, in the structure of the institution itself, and it is all the more powerful for being invisible to the people inside it. A hospital has every reason to be superb at treating the patient who has arrived and no structural reason whatsoever to reduce the number of patients who arrive. It grows by treating sickness. It cannot grow by preventing it, because prevention removes the very throughput on which the growth depends.
This is why the buildings keep getting bigger while prevention keeps getting smaller. The visible, fundable, expansionary direction of a hospital is always toward more capacity to treat — a new wing, a new scanner, a new intensive-care floor, a new cardiac catheterisation suite. These are real improvements and they save real lives at the acute event. But each one deepens the institution's commitment to the reactive model, because each one is another large fixed cost that must be recovered through volume. No hospital in the country has ever expanded by opening a prevention wing, because there is no revenue line under a prevention wing. The direction of institutional growth and the direction of population health have quietly come apart, and the growth is winning.
The money pays for the procedure, not for the person staying well
Underneath the hospital's incentives sits the deeper structure that shapes all of them — the way Nigerian healthcare is paid for. The dominant modes of health financing in the country all share a feature that is fatal to prevention: they pay for the treatment of sickness and they do not pay for the maintenance of health.
The largest single mode is straightforward out-of-pocket payment. Most Nigerian healthcare, by value, is bought at the point of need by the patient or the patient's family, in cash, when something has gone wrong. Out-of-pocket payment is, by its nature, reactive money. Nobody wakes up well and pays cash for the prevention of a disease they cannot feel. The money moves when the symptom moves, which means it moves late, which means it funds the crisis and not the interval before it. A financing model in which the patient only spends when the patient is frightened is a financing model that structurally cannot fund the years of quiet management that would have kept the fright from arriving.
The second mode, layered over the first, is fee-for-service — the arrangement under which the provider is paid per act performed. The consultation is billed, the scan is billed, the procedure is billed, the admission is billed. Fee-for-service pays the provider more for doing more, and it pays nothing for doing the thing that prevention actually requires, which is often to do less — to talk to the patient, to adjust a tablet, to phone in a fortnight, to keep the patient out of the theatre altogether. A payment model that rewards acts performed will, over time and without anyone intending it, produce a system oriented toward performing acts. The act it least rewards is the one that prevents future acts.
The third mode is the HMO structure that covers the formally employed minority. In principle a capitated health plan — one that receives a fixed sum per member and therefore has a genuine financial reason to keep that member well — is the one financing arrangement in the country whose incentives point toward prevention. In practice the Nigerian HMO model has largely reproduced the reactive logic around it. The plans tend to be thin, the covered interventions tend to be the acute ones, the annual physical is a benefit on paper more often than a managed reality, and the follow-up between encounters — the phone call, the medication review, the second reading of last year's results against this year's — is not a thing the structure funds or measures. The one model that could have paid for keeping people well has, for the most part, been built to pay for treating them once they are not.
Put the three together and the picture is complete. At every level at which money enters Nigerian healthcare, it enters as payment for the treatment of the sick and almost never as payment for the keeping of the well. A system will produce what it pays for. This one pays for sickness, comprehensively, and for health, hardly at all — and it then expresses genuine puzzlement that the wards are full.
Busyness is not progress
The conclusion this forces is not a comfortable one, and it is worth stating without softening. A busy hospital is not, in itself, evidence that a health system is working. It may be evidence of exactly the opposite. When the emergency entrances fill and the wards fill and the throughput climbs year on year while the underlying burden of chronic disease also climbs, what is being measured is not the system defeating disease. It is the system harvesting the failures of prevention that the same structure made inevitable. The busyness is downstream of the prevention gap, not a substitute for closing it.
This is the deeper reason a country can pour capital into hospitals for two decades and watch its chronic-disease outcomes improve only slowly. The capital went, sensibly and understandably, into the reactive apparatus — the buildings that are excellent at the crisis. But a system optimised end to end to treat the sick is not neutral toward prevention. It is structurally hostile to it, because prevention removes the throughput that the whole apparatus is built and funded to process. You cannot bolt prevention onto a reactive system as an afterthought and expect it to hold, because the incentives of the reactive system will quietly starve it. Prevention has to be built by someone whose economics are aligned with the empty bed rather than the full one — and almost nobody in the current structure is.
The medical-travel outflow, which runs by responsible estimates north of a billion US dollars a year, is often read as a verdict on the quality of Nigerian acute care. It is partly that. But a great deal of what the wealthy fly abroad to buy is not superior crisis treatment. It is the thing the domestic system does not sell at any price — the sustained relationship that watches the interval, catches the disease early, and keeps the patient out of the ward in the first place. The country has built an impressive machine for treating people once they are sick. It has barely begun to build the far quieter machine for keeping them from getting there.
What Kinedic is building
Our practice operates from Mabushi, Abuja, with clinical anchoring at Brookfield Clinics six hundred metres away for imaging, inpatient capacity, and acute escalation when it is genuinely needed. The point of the model, though, is to make the acute escalation rarer — to move the centre of gravity from the crisis to the interval before it. The named-physician premise is what makes that possible. Each member has a primary physician who carries the file across every encounter, who holds the panel small enough that the interval can actually be watched, and whose economics are aligned with the member staying well rather than with the volume of procedures performed. The records are held across the lifetime of the relationship, so that a blood pressure or a creatinine or a fasting glucose can be read as a trend across years rather than scored afresh against a reference range each time. The follow-up culture — the Thursday call, the check that the first pack was refilled, the reading of last year's labs against this year's — is built into the calendar of the practice rather than left to the patient to remember. The WhatsApp line is a real channel staffed during working hours, so that the interval has a person attached to it and the loop can be closed before it becomes an admission.
None of this is a rejection of the hospital. The hospital is indispensable, and Brookfield is the hospital. What the model rejects is the idea that the hospital is the whole of medicine — that care begins at the emergency entrance and ends at discharge, and that the years in between belong to nobody. The years in between are where chronic disease is won or lost. Building a practice whose incentives point toward the empty bed rather than the full one is the unglamorous, unfashionable work the country has mostly not funded. It is the work most likely to change the outcomes that two decades of buildings have not.
If you are weighing the model — for yourself, a parent, or your organisation — start a conversation with us. The first conversation is private and costs nothing.